| Applications: |
Immunodepletion/Immunocompetition |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
BMP8 Blocking Peptide is synthetically produced from the 160-200 sequence and is suitable for use in western blot applications. |
| Formulation: |
Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction: |
Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Gene Symbol: |
BMP8B |
| Gene ID: |
656 |
| Uniprot ID: |
BMP8B_HUMAN |
| Immunogen Region: |
160-200 |
| Immunogen: |
Synthetic peptide taken within amino acid region 160-200 on human BMP8 protein |
| Function | Induces cartilage and bone formation. May be the osteoinductive factor responsible for the phenomenon of epithelial osteogenesis. Plays a role in calcium regulation and bone homeostasis. |
| Peptide Name | Bone Morphogenetic Protein 8bBmp-8Bmp-8bOsteogenic Protein 2Op-2 |
| Cellular Localisation | Secreted |
| Alternative Peptide Names | Bone Morphogenetic Protein 8b proteinBmp-8 proteinBmp-8b proteinOsteogenic Protein 2 proteinOp-2 proteinBMP8B proteinBMP8 protein |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
